-
Innovation Ranking
NewInnovation Ranking – Shanghai Kehua Bio-engineering Co Ltd
Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s product portfolio includes COVID-19 products, immunologic diagnosis, biochemical diagnosis, molecular diagnosis and POCT (point-of-care testing) products. It also offers comprehensive services for regional medical communities. KHB established R&D centers and production bases in many countries and regions including Italy. The company has sales support facilities in major cities in China and markets products in China...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BAT-6026 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BAT-6026 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BAT-6026 in Solid Tumor Drug Details: BAT-6026 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Interferon Gamma-1b in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Interferon Gamma-1b in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Interferon Gamma-1b in Non-Small Cell Lung Cancer Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Interferon Gamma-1B in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Interferon Gamma-1B in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Interferon Gamma-1B in Metastatic Breast Cancer Drug Details: Human...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Interferon Gamma-1b in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Interferon Gamma-1b in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Interferon Gamma-1b in Triple-Negative Breast Cancer (TNBC) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Liraglutide in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Liraglutide in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liraglutide in Parkinson's Disease Drug Details: Liraglutide (Victoza) is a potent anti-diabetic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Liraglutide in Pouchitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Liraglutide in Pouchitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liraglutide in Pouchitis Drug Details: Liraglutide (Victoza) is a potent anti-diabetic agent. It...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BCMA-GPRC5D CAR-T Cells in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BCMA-GPRC5D CAR-T Cells in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BCMA-GPRC5D CAR-T Cells in Relapsed Multiple Myeloma Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BCMA-GPRC5D CAR-T Cells in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BCMA-GPRC5D CAR-T Cells in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BCMA-GPRC5D CAR-T Cells in Refractory Multiple Myeloma Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CABA-201 in Lupus Nephritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CABA-201 in Lupus Nephritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CABA-201 in Lupus Nephritis Drug Details: CABA-201 is under development for...